Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trialThomas Powles, Şeyda Gündüz, Yen‐Hwa Chang et al.|Nature Medicine|2024Cited by 35
Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricleFrank Y. Lin, D. Williams Parsons, Leomar Y. Ballester et al.|Molecular Case Studies|2016Cited by 30